130 related articles for article (PubMed ID: 14593710)
1. Proteomic approaches for the identification of cell cycle-related drug targets.
Flory MR; Aebersold R
Prog Cell Cycle Res; 2003; 5():167-71. PubMed ID: 14593710
[TBL] [Abstract][Full Text] [Related]
2. The contemporary drug development process: advances and challenges in preclinical and clinical development.
Garrett MD; Walton MI; McDonald E; Judson I; Workman P
Prog Cell Cycle Res; 2003; 5():145-58. PubMed ID: 14593708
[TBL] [Abstract][Full Text] [Related]
3. Mining the NCI screening database: explorations of agents involved in cell cycle regulation.
Wallqvist A; Monks A; Rabow AA; Thanki N; Shoemaker RH; Covell DG
Prog Cell Cycle Res; 2003; 5():173-9. PubMed ID: 14593711
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
Rodríguez-González A; Ramírez de Molina A; Benítez-Rajal J; Lacal JC
Prog Cell Cycle Res; 2003; 5():191-201. PubMed ID: 14593713
[TBL] [Abstract][Full Text] [Related]
5. Yeast genomics and proteomics in drug discovery and target validation.
Parsons AB; Geyer R; Hughes TR; Boone C
Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
[TBL] [Abstract][Full Text] [Related]
6. Use of proteomics to study chemosensitivity.
Poland J; Wandschneider S; Urbani A; Bernardini S; Federici G; Sinha P
Methods Mol Med; 2005; 111():267-81. PubMed ID: 15911985
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs.
Kohno M; Pouyssegur J
Prog Cell Cycle Res; 2003; 5():219-24. PubMed ID: 14593716
[TBL] [Abstract][Full Text] [Related]
9. Integrative oncoproteomics strategies for anticancer drug discovery.
Liu R; Wang K; Yuan K; Wei Y; Huang C
Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
[TBL] [Abstract][Full Text] [Related]
10. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle and drug sensitivity.
Kazi A; Dou QP
Methods Mol Med; 2005; 111():33-42. PubMed ID: 15911969
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.
Park IW; Reddy MV; Reddy EP; Groopman JE
Oncogene; 2007 Aug; 26(38):5635-42. PubMed ID: 17369860
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle: proteomics gives it a spin.
Archambault V
Expert Rev Proteomics; 2005 Aug; 2(4):615-25. PubMed ID: 16097893
[TBL] [Abstract][Full Text] [Related]
14. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway.
Ye M; Luo X; Li L; Shi Y; Tan M; Weng X; Li W; Liu J; Cao Y
Cancer Lett; 2007 Dec; 258(2):199-207. PubMed ID: 18029087
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic approaches for studying phosphotyrosine signaling.
Ding SJ; Qian WJ; Smith RD
Expert Rev Proteomics; 2007 Feb; 4(1):13-23. PubMed ID: 17288512
[TBL] [Abstract][Full Text] [Related]
16. Shotgun proteomics using the iTRAQ isobaric tags.
Aggarwal K; Choe LH; Lee KH
Brief Funct Genomic Proteomic; 2006 Jun; 5(2):112-20. PubMed ID: 16772272
[TBL] [Abstract][Full Text] [Related]
17. Stopping replication, at the beginning.
Jackson PK
Nat Chem Biol; 2008 Jun; 4(6):331-2. PubMed ID: 18488006
[No Abstract] [Full Text] [Related]
18. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
19. A novel method of screening cell-cycle blockers as candidates for anti-tumor reagents using yeast as a screening tool.
Tsuchiya E; Yukawa M; Ueno M; Kimura K; Takahashi H
Biosci Biotechnol Biochem; 2010; 74(2):411-4. PubMed ID: 20139596
[TBL] [Abstract][Full Text] [Related]
20. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
